Answers are grounded in this paper and cite their sources.
Randomized trial shows that aspirin lowers cardiovascular disease risk linked to inflammation in healthy men, suggesting new preventive strategies.
The base-line plasma concentration of C-reactive protein predicts the risk of future myocardial infarction and stroke. Moreover, the reduction associated with the use of aspirin in the risk of a first myocardial infarction appears to be directly related to the level of C-reactive protein, raising the possibility that antiinflammatory agents may have clinical benefits in preventing cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Ridker et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: